Company overview
Elemental Machines provides a LabOps connectivity platform with IoT sensors and cloud-based software for monitoring lab equipment, environments, workflows, and utilization in pharmaceutical and life sciences labs. It offers real-time and historical data analytics, including the Usage Solution for optimizing equipment management and bioreactor monitoring solutions. The platform supports R&D, biotech, pharma, and manufacturing operations with AI-powered insights to enhance efficiency and compliance.
Elemental Machines is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include labops platform, pharma monitoring, iot sensors, equipment utilization, life sciences compliance.
Products and technologies associated with Elemental Machines include Equipment — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://elementalmachines.com/
- Markets served
- United States & Americas
- Keywords
- labops platform, pharma monitoring, iot sensors, equipment utilization, life sciences compliance
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What monitoring capabilities does Elemental Machines offer for pharma labs?
- IoT sensors monitor temperature, humidity, equipment performance, workflows, utilization, and bioreactors, with cloud-based dashboards for real-time and historical data visualization.
- Does Elemental Machines support regulatory compliance like GxP or GMP?
- The platform maintains GMP/GLP readiness and offers some GxP features oriented toward research labs, but lacks full FDA 21 CFR Part 11 compliance with electronic signatures and audit trails needed for manufacturing.
- What industries and geographies does Elemental Machines serve?
- It serves global R&D, biotech, pharma, CLIA, QC labs, biobanks, and manufacturing facilities worldwide through scalable, cloud-based solutions.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
